Gault Cheryl bought RAPP
November 26, 2025 · Form 4 insider transaction
Gault Cheryl bought 5,000 shares of Rapport Therapeutics, Inc. at $1.80 per share, a transaction worth $9.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$1.80
Total value
$9.0K
InsiderGault Cheryl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after176,928
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.